Company intelligence / Profile preview

Pharmaceutical Research Unit

Ownership: Private
Employees: ~69
Development stage: Other

Overview

Pharmaceutical Research Unit (PRU) is the first contract research organization established in Jordan (1993), offering comprehensive biopharmaceutical services including clinical trial setup and management, bioanalysis, data management/statistics, medical/regulatory writing. It holds accreditations from major regulatory agencies such as the US FDA and EU authorities. PRU has supported over 100 pharmaceutical companies globally with expertise spanning oncology drugs to biosimilars[1][2].

Therapeutic areas: OncologyEndocrinologyImmunology
Modalities: Small moleculeBiologicBiosimilar
Industry: Contract Research Organization

Partnerships

Works with >100 pharmaceutical companies worldwide as clients

Beyond the preview

Go deeper on Pharmaceutical Research Unit.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pharmaceutical Research Unit.

Explore the full profile